UBS ASSET MANAGEMENT AMERICAS LLC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$289,942
+74.7%
28,068
+89.0%
0.00%
Q2 2023$165,9890.0%14,8470.0%0.00%
Q1 2023$165,989
-99.9%
14,847
+67.1%
0.00%
Q1 2022$220,486,000
-22.6%
8,8870.0%0.00%
Q4 2021$285,006,000
+19.2%
8,887
+33.7%
0.00%
Q3 2021$239,123,000
-49.5%
6,646
-38.1%
0.00%
Q2 2021$473,937,00010,7420.00%
Other shareholders
PULMONX CORP shareholders Q1 2022
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 815,019$37,279,00040.66%
Yu Fan 303,030$13,861,00036.18%
ABG Innovation Capital Partners III GP Ltd 833,333$38,117,00018.73%
KPCB XIII Associates, LLC 994,971$45,510,0009.36%
Iron Triangle Partners LP 600,000$27,444,0003.49%
Miura Global Management 405,000$18,525,0003.31%
GREAT POINT PARTNERS LLC 114,345$5,230,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 937,032$42,860,0000.90%
ADAMS STREET PARTNERS LLC 114,661$5,245,0000.84%
RTW INVESTMENTS, LP 1,129,600$51,668,0000.81%
View complete list of PULMONX CORP shareholders